In particular, a relationship between the increase of tissue activation of MMP9 and cognitive impairment has been hypothesized in MCI and AD [62], revealing that the expression of MMP9 was upregulated in AD patients in neurofibrillary tangles, neuronal cytoplasm, vascular tissue, and amyloid plaques [63]. This evidence concerns the gene MMP9 and Alzheimer disease.